BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31601121)

  • 1. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
    Krys D; Hamann I; Wuest M; Wuest F
    FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
    Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
    FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
    Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
    J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
    Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
    Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
    Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.
    Mangravite LM; Xiao G; Giacomini KM
    Am J Physiol Renal Physiol; 2003 May; 284(5):F902-10. PubMed ID: 12527552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.
    Muñoz G; San Martín R; Farías M; Cea L; Vecchiola A; Casanello P; Sobrevia L
    J Cell Physiol; 2006 Dec; 209(3):826-35. PubMed ID: 16924660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
    Català A; Pastor-Anglada M; Caviedes-Cárdenas L; Malatesta R; Rives S; Vega-García N; Camós M; Fernández-Calotti P
    Oncotarget; 2016 Aug; 7(31):49786-49799. PubMed ID: 27391351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae.
    Vickers MF; Zhang J; Visser F; Tackaberry T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):361-73. PubMed ID: 15043160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
    Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
    Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.
    Plotnik DA; McLaughlin LJ; Chan J; Redmayne-Titley JN; Schwartz JL
    Nucl Med Biol; 2011 Oct; 38(7):979-86. PubMed ID: 21982569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae.
    Vickers MF; Kumar R; Visser F; Zhang J; Charania J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Biochem Cell Biol; 2002; 80(5):639-44. PubMed ID: 12440703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
    Elwi AN; Damaraju VL; Kuzma ML; Mowles DA; Baldwin SA; Young JD; Sawyer MB; Cass CE
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1439-51. PubMed ID: 19297449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
    Schelhaas S; Wachsmuth L; Viel T; Honess DJ; Heinzmann K; Smith DM; Hermann S; Wagner S; Kuhlmann MT; Müller-Tidow C; Kopka K; Schober O; Schäfers M; Schneider R; Aboagye EO; Griffiths J; Faber C; Jacobs AH
    J Nucl Med; 2014 Jun; 55(6):983-8. PubMed ID: 24777288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.
    Paproski RJ; Young JD; Cass CE
    Biochem Pharmacol; 2010 Feb; 79(4):587-95. PubMed ID: 19788890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.
    Molina-Arcas M; Moreno-Bueno G; Cano-Soldado P; Hernández-Vargas H; Casado FJ; Palacios J; Pastor-Anglada M
    Biochem Pharmacol; 2006 Dec; 72(12):1646-56. PubMed ID: 16965766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.